Padraig R Warde, MB BCh, FRCPC

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Keywords: clinical trials, prostate cancer, testicular cancer

The Clinical Specialist Radiation Therapist (CSRT): A case study exploring the effectiveness of a new advanced practice role in Canada.

J Med Radiat Sci. 2018 Jun;65(2):86-96

Harnett N, Bak K, Lockhart E, Ang M, Zychla L, Gutierrez E, Warde P

Gene Expression Signatures Prognostic for Relapse in Stage I Testicular Germ Cell Tumors (TGCT).

BJU Int. 2018 May 03;:

Lewin J, Soltan Ghoraie L, Bedard PL, Hamilton RJ, Chung P, Moore M, Jewett MAS, Anson-Cartwright L, Virtanen C, Winegarden N, Tsao J, Warde P, Sweet J, Haibe-Kains B, Hansen AR

Do radiation oncology outreach clinics affect the use of radiotherapy?

Radiother Oncol. 2018 Feb 22;:

McLaughlin PY, Kong W, de Metz C, Hanna TP, Brundage M, Warde P, Gutierrez E, Mackillop WJ

Serum miRNA predicts viable disease post-chemotherapy in testicular non-seminoma germ cell tumor patients.

J Urol. 2018 Feb 20;:

Leão R, van Agthoven T, Figueiredo A, Jewett MAS, Fadaak K, Sweet J, Ahmad AE, Anson-Cartwright L, Chung P, Hansen A, Warde P, Castelo-Branco P, O'Malley M, Bedard PL, Looijenga LHJ, Hamilton RJ

A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.

Eur Urol Focus. 2018 Feb 07;:

Leão R, Nayan M, Punjani N, Jewett MAS, Fadaak K, Garisto J, Lewin J, Atenafu EG, Sweet J, Anson-Cartwright L, Boström P, Chung P, Warde P, Bedard PL, Bagrodia A, Freifeld Y, Power N, Winquist E, Hamilton RJ

Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach.

Can Urol Assoc J. 2017 Dec 01;:

Lieng H, Warde P, Bedard P, Hamilton RJ, Hansen AR, Jewett MAS, O'malley M, Sweet J, Chung P

Testicular seminoma: Scattered radiation dose to the contralateral testis in the modern era.

Pract Radiat Oncol. 2018 Jan 03;:

Lieng H, Chung P, Lam T, Warde P, Craig T

Regional Therapy Might Have a Role.

Int J Radiat Oncol Biol Phys. 2017 Nov 01;99(3):511

Chung P, Warde P

Improving bone health in men with prostate cancer receiving androgen deprivation therapy: Results of a randomized phase 2 trial.

Cancer. 2017 Dec 06;:

Alibhai SMH, Breunis H, Timilshina N, Hamidi MS, Cheung AM, Tomlinson GA, Manokumar T, Samadi O, Sandoval J, Durbano S, Warde P, Jones JM